VIENNA, Va., May 7 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION (Amex:
CVM) announced that Geert Kersten, Chief Executive Officer, will be
presenting at the BIO 2007 Business Forum, the Biotechnology Industry
Organization's Annual International Convention being held at the Boston
Convention & Exhibition Center from May 6-9, 2007. Mr. Kersten's
presentation will be on Tuesday, May 8th, at 9:15 a.m. local time in Room
E.
The BIO Business Forum is the largest partnering and networking program
in the industry. It is a program that offers pharmaceutical companies,
biotechnology companies, academic research institutions and investors from
around the world the unique opportunity to gather in one place at one time
to learn about each other and to meet one-on-one to discuss business
opportunities of mutual interest.
The Biotechnology Industry Organization (BIO), founded in 1993, is a
nonprofit association that represents more than 1,100 biotechnology
companies, state and international affiliates, and related organizations.
The BIO International Convention offers attendees an opportunity to meet
with every key player in the biotechnology industry. Program participants
include researchers, academia, entrepreneurs, venture capitalists, and
others who will soon be recognized for their vision and achievement. Her
Majesty Queen Noor of Jordan and Michael J. Fox are the keynote speakers
this year. Additional information about the International Convention and
the Business Forum is available at http://www.bio2007.org.
CEL-SCI Corporation is developing new immune system based treatments
for cancer and infectious diseases. The Company has received the go-ahead
from the U.S. FDA and the Canadian Regulators to conduct a Phase III
clinical trial in advanced primary head and neck cancer patients with its
lead product Multikine(R). CEL-SCI's other products, which are currently in
pre-clinical stage and have been funded with U.S. government support, have
shown protection against a number of diseases in animal tests and are
currently being tested against diseases associated with bio-defense and
avian flu. The Company has operations in Vienna, Virginia and Baltimore,
Maryland.
SOURCE CEL-SCI Corporation
 back to top
Related links:
http://www.cel-sci.com
http://www.bio2007.org
CONTACT:
Gavin de Windt of CEL-SCI Corporation,
+1-703-506-9460
|
